A detailed history of Mittelman Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Mittelman Wealth Management holds 4,440 shares of NVS stock, worth $505,938. This represents 0.31% of its overall portfolio holdings.

Number of Shares
4,440
Previous 4,440 -0.0%
Holding current value
$505,938
Previous $429 Million 10.06%
% of portfolio
0.31%
Previous 0.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$95.27 - $108.47 $422,998 - $481,606
4,440 New
4,440 $429 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mittelman Wealth Management Portfolio

Follow Mittelman Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mittelman Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mittelman Wealth Management with notifications on news.